Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Connectivity Changes in Ketamine Assisted Psychotherapy for PTSD
NCT06036511Phase 2Withdrawn
- Sponsor
- The University of New Mexico
- Start
- Dec 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ketamine in post-traumatic stress disorder (PTSD), sponsored by The University of New Mexico. Primary endpoints: Post-Traumatic Stress Disorder Severity and Changes in functional connectivity. Planned start Dec 2023; status: withdrawn.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06036511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06036511.